Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury
Chronic consequences of mild traumatic brain injury (mTBI) are heterogeneous, but may be treatable with targeted medical and rehabilitation interventions. A biological signature for the likelihood of response to therapy (i.e., ?predictive? biomarkers) would empower personalized medicine post-mTBI. T...
Main Authors: | Shawn R. Eagle, Ava M. Puccio, Denes V. Agoston, Ryan Soose, Michael Mancinelli, Rachel Nwafo, Peyton McIntyre, Allison Agnone, Savannah Tollefson, Michael Collins, Anthony P. Kontos, Walter Schneider, David O. Okonkwo |
---|---|
Format: | Article |
Language: | English |
Published: |
Mary Ann Liebert
2023-06-01
|
Series: | Neurotrauma Reports |
Subjects: | |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/NEUR.2023.0003 |
Similar Items
-
Association of Plasma Biomarkers with Sleep Outcomes and Treatment Response After Mild Traumatic Brain Injury
by: Shawn R. Eagle, et al.
Published: (2023-04-01) -
Eye movements in mild traumatic brain injury: Clinical challenges
by: Matthew A. McDonald, et al.
Published: (2022-06-01) -
Eye movements in mild traumatic brain injury: Ocular biomarkers
by: Matthew A. McDonald, et al.
Published: (2022-06-01) -
Diagnostic performance of point-of-care ubiquitin carboxy-terminal Hydrolase-L1 assay in distinguishing imaging abnormalities in traumatic brain injury: A TRACK-TBI cohort study
by: Kevin K. Wang, et al.
Published: (2023-01-01) -
Educating the masses: suggestions for improving online concussion information via the mainstream media
by: Osman Hassan Ahmed, et al.
Published: (2017-03-01)